Biotech Stock Could Turn 4-Year Peak Into Records

Core Insights - BridgeBio Pharma Inc (NASDAQ:BBIO) stock has increased by 3.3% to $70.36, reaching a four-year high of $70.60, with a year-over-year gain of 154.9% [1] - The stock's recent performance is supported by low implied volatility, with a Schaeffer's Volatility Index (SVI) of 44%, ranking in the 13th percentile of its annual range, indicating potential for further gains [2] - A high put/call volume ratio of 1.03 and a Schaeffer's put/call open interest ratio (SOIR) of 1.52 suggest a prevailing pessimism in options trading, which could lead to continued upward momentum for the stock [4] - An increase in short interest by 12.8% indicates that 11.8% of BBIO's float is shorted, with a potential for a short squeeze as it would take over eight days for short sellers to cover their positions [5]